A new $50 million investment fund will back Penn life sciences start-upsAlveus Therapeutics, a Philadelphia start-up treating obesity, debuted with $160M in fundingS&P downgraded ChristianaCare’s credit ratingTemple University Hospital is being investigated by CMS over its care of a homeless patient who diedDrug distribution giant Cencora is boosting its reach in medical specialtiesCalifornia biotech BioMarin will pay $4.8 billion for Amicus Therapeutics, a rare-disease company with a presence in Philadelphia One year of inspections at Fox Chase Cancer Center: November 2024 - October 2025Drexel University signed a lease to consolidate medical college research in University CityChristianaCare and Virtua Health have ended merger talksWhy Philadelphia loses promising biotech firms to Boston, San Francisco, and San Diego
California biotech BioMarin will pay $4.8 billion for Amicus Therapeutics, a rare-disease company with a presence in Philadelphia
California biotech BioMarin will pay $4.8 billion for Amicus Therapeutics, a rare-disease company with a presence in Philadelphia
